The Department of Health and Human Services, specifically the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC), are seeking proposals for Small Business Innovation Research (SBIR) contract proposals. The specific topic of the solicitation is "Cancer Prevention and Treatment Clinical Trials Tools for Recruitment and Retention of Diverse Populations".
The goal of this solicitation is to address the slow and incomplete accrual of diverse participants in cancer prevention and treatment clinical trials, which hampers drug development and medical progress. The solicitation aims to develop innovative tools that enhance recruitment, retention, and adherence to clinical trials. These tools should improve communication between study staff and participants, build long-term trusted relationships, improve the study participation experience, and reduce the burden of clinical trials for both staff and participants.
The solicitation accepts Fast-Track proposals and Direct-to-Phase II proposals. The anticipated number of awards is 3-5. The budget for Phase I is up to $400,000 for up to 12 months, and for Phase II, it is up to $2,000,000 for up to 2 years. Proposals that exceed the budget or project duration may not be funded.
This topic aligns with the Cancer Moonshot Blue Ribbon Panel recommendation to establish a network for direct patient engagement. The solicitation is closed, and the application due date was November 14, 2023. More information can be found on the SBIR topic link (https://www.sbir.gov/node/2451721) and the solicitation agency URL (https://sam.gov/opp/aa72581c848947f0b61c15062e604862/view).